Cyteir Therapeutics, Inc.
CYT
Revenue
0.00
0.000.00%
-Assets
131.01M
▼-3.38M▼-2.51%
3 Months ChangeLiabilities
5.98M
▼-623.00k▼-9.44%
3 Months ChangeFree Cash Flow
-12.36M
▼-5.81M▼-88.63%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-03-20
Form 8-K
ID: 0000950170-24-034247
2024-03-07
Form 8-K
ID: 0000950170-24-028044
2023-12-27
Form 8-K
ID: 0000950170-23-073295
2023-12-07
Form 8-K
ID: 0000950170-23-068797
2023-12-05
Form 8-K
ID: 0000950170-23-068149
2023-11-17
Form 8-K
ID: 0000950170-23-064788
2023-11-06
Form 10-Q
ID: 0000950170-23-059370
2023-10-12
Form 8-K
ID: 0000950170-23-053002
2023-10-05
Form 8-K
ID: 0000950170-23-052188
2023-08-07
Form 10-Q
ID: 0000950170-23-039033